董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Erqi Wang | 男 | Chief Executive Officer, Director, Chairman of the Board | 56 | 未披露 | 10712.61 | 2025-06-20 |
| Yanru Guo | 女 | Independent Director | 50 | 未披露 | 未持股 | 2025-06-20 |
| Ziqiang Wang | 男 | Chief Financial Officer and Director | 55 | 未披露 | 未持股 | 2025-06-20 |
| Oliver St. Clair Franklin | 男 | Independent Director | 79 | 未披露 | 未持股 | 2025-06-20 |
| 童嘉元 | 男 | Independent Director | 51 | 未披露 | 未持股 | 2025-06-20 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Erqi Wang | 男 | Chief Executive Officer, Director, Chairman of the Board | 56 | 未披露 | 10712.61 | 2025-06-20 |
| Ziqiang Wang | 男 | Chief Financial Officer and Director | 55 | 未披露 | 未持股 | 2025-06-20 |
董事简历
中英对照 | 中文 | 英文- Erqi Wang
-
Erqi Wang自2020年1月起担任中进医疗器材股份有限公司的首席执行官和董事长，自2006年10月成立公司以来，他一直担任常州中金的首席执行官和董事长。Wang先生也是中进医疗器材股份有限公司研发部门的核心领导。此前，2009年7月至2018年3月，Wang先生现任三桂康复设备上海有限公司董事总经理，他还担任江苏残疾人福利基金会名誉副会长，是中国轮椅协会的成员，Wang先生在中国获得了多项奖项，作为企业家和科学家，包括2013年度“常州市领先的企业家人才”和“中国的杰出企业家”。2008年“首届江苏省工业设计大赛银奖”。Wang先生拥有东北大学工程力学博士学位，作为第一位发明人拥有16项发明专利。
Erqi Wang,he has served as CEO and Chairman of Changzhou Zhongjin since he founded the company in October 2006. Mr. Wang is also a core leader of Jin Medical International Ltd. R&D department. Previously, from July 2009 to March 2018, Mr. Wang served as the managing director of Sangui Rehabilitation Equipment (Shanghai) Co., Ltd. Currently, he also serves as the Honorary Vice President of Jiangsu Welfare Foundation for the Disabled and is a member of the China Wheelchair Association Mr. Wang has received a number of awards in China for his achievements as an entrepreneur and as a scientist, including the "Leading Entrepreneurial Talent in Changzhou City" in 2013, and the "Silver Medal in the First Jiangsu Industrial Design Competition" in 2008. Mr. Wang holds a PhD in Engineering Mechanics from Tohoku University, and owns 16 invention patents as the first inventor. - Erqi Wang自2020年1月起担任中进医疗器材股份有限公司的首席执行官和董事长，自2006年10月成立公司以来，他一直担任常州中金的首席执行官和董事长。Wang先生也是中进医疗器材股份有限公司研发部门的核心领导。此前，2009年7月至2018年3月，Wang先生现任三桂康复设备上海有限公司董事总经理，他还担任江苏残疾人福利基金会名誉副会长，是中国轮椅协会的成员，Wang先生在中国获得了多项奖项，作为企业家和科学家，包括2013年度“常州市领先的企业家人才”和“中国的杰出企业家”。2008年“首届江苏省工业设计大赛银奖”。Wang先生拥有东北大学工程力学博士学位，作为第一位发明人拥有16项发明专利。
- Erqi Wang,he has served as CEO and Chairman of Changzhou Zhongjin since he founded the company in October 2006. Mr. Wang is also a core leader of Jin Medical International Ltd. R&D department. Previously, from July 2009 to March 2018, Mr. Wang served as the managing director of Sangui Rehabilitation Equipment (Shanghai) Co., Ltd. Currently, he also serves as the Honorary Vice President of Jiangsu Welfare Foundation for the Disabled and is a member of the China Wheelchair Association Mr. Wang has received a number of awards in China for his achievements as an entrepreneur and as a scientist, including the "Leading Entrepreneurial Talent in Changzhou City" in 2013, and the "Silver Medal in the First Jiangsu Industrial Design Competition" in 2008. Mr. Wang holds a PhD in Engineering Mechanics from Tohoku University, and owns 16 invention patents as the first inventor.
- Yanru Guo
-
Yanru Guo，为独立董事。Guo女士自2014年3月起任职于纳斯达克上市公司尚高有限公司，担任首席会计师。Guo女士在根据美国公认会计原则和SEC法规审查和确保中期和年度合并财务报表准确性方面拥有宝贵的经验和技能。她还熟悉美国通用会计准则、国际财务报告准则和CAS，在纳斯达克上市公司拥有超过10年的会计经验。Guo女士于2008年4月至2012年5月任职于北京移动互动有限公司，担任财务经理。2003年6月至2027年5月，Guo女士任职于北京盈科信息技术有限公司，担任财务主管。Guo女士在东北财经大学获得会计学硕士学位，并在华北航天工程学院获得经济学和管理与会计学学士学位。Guo女士还持有中国注册会计师证书。
Yanru Guo,is an independent director. Ms. Guo has been working at Shineco, Inc., a Nasdaq-listed company, as chief accountant since March 2014. Ms. Guo possesses valuable experience and skills in reviewing and ensuring the accuracy of interim and annual consolidated financial statements under US GAAP and SEC regulations. She is also familiar with U.S. GAAP, IFRS, and CAS, with over 10 years of accounting experience in Nasdaq-listed companies. From April 2008 to May 2012, Ms. Guo worked at Beijing Mobile Interactive Co. Ltd as a finance manager. From June 2003 to May 2027, Ms. Guo worked at Beijing Pacific Century Info-Tech Co., Ltd. as a financial executive. Ms. Guo received a master's degree in accounting at Dongbei University of Finance and a Economics and bachelor's degree in management and accounting from Huabei Institute of Astronautical Engineering. Ms. Guo also holds a CPA Certificate in China. - Yanru Guo，为独立董事。Guo女士自2014年3月起任职于纳斯达克上市公司尚高有限公司，担任首席会计师。Guo女士在根据美国公认会计原则和SEC法规审查和确保中期和年度合并财务报表准确性方面拥有宝贵的经验和技能。她还熟悉美国通用会计准则、国际财务报告准则和CAS，在纳斯达克上市公司拥有超过10年的会计经验。Guo女士于2008年4月至2012年5月任职于北京移动互动有限公司，担任财务经理。2003年6月至2027年5月，Guo女士任职于北京盈科信息技术有限公司，担任财务主管。Guo女士在东北财经大学获得会计学硕士学位，并在华北航天工程学院获得经济学和管理与会计学学士学位。Guo女士还持有中国注册会计师证书。
- Yanru Guo,is an independent director. Ms. Guo has been working at Shineco, Inc., a Nasdaq-listed company, as chief accountant since March 2014. Ms. Guo possesses valuable experience and skills in reviewing and ensuring the accuracy of interim and annual consolidated financial statements under US GAAP and SEC regulations. She is also familiar with U.S. GAAP, IFRS, and CAS, with over 10 years of accounting experience in Nasdaq-listed companies. From April 2008 to May 2012, Ms. Guo worked at Beijing Mobile Interactive Co. Ltd as a finance manager. From June 2003 to May 2027, Ms. Guo worked at Beijing Pacific Century Info-Tech Co., Ltd. as a financial executive. Ms. Guo received a master's degree in accounting at Dongbei University of Finance and a Economics and bachelor's degree in management and accounting from Huabei Institute of Astronautical Engineering. Ms. Guo also holds a CPA Certificate in China.
- Ziqiang Wang
-
Ziqiang Wang自2020年1月起担任中进医疗器材股份有限公司的首席财务官，自2008年5月起担任常州中金的首席财务官。曾于2006年1月至2008年4月担任日田常州电气有限公司首席财务官；1996年1月至2005年12月任常州伺服电机有限公司财务部经理。1992年8月至1995年12月，他在常州宝马集团担任财务官。Wang先生于1992年毕业于杭州电子技术学院，获得工业管理学士学位，2013年被江苏省人力资源和社会保障厅认证为高级经济学家。
Ziqiang Wang,as the CFO of Changzhou Zhongjin since May 2008. Previously, from January 2006 to April 2008, he served as the CFO of Nikoda (Changzhou) Electric Co., Ltd; from January 1996 to December 2005, he served as the manager of the financial department at Changzhou Servo Motor Co., Ltd.; and from August 1992 to December 1995, he served as a financial officer at Changzhou BMW Group. Mr. Wang graduated from Hangzhou Institute of Electronic Technology with a Bachelor's degree in Industrial Management in 1992, and was certified as a Senior Economist by the Department of Human Resources and Social Security of Jiangsu Province in 2013. - Ziqiang Wang自2020年1月起担任中进医疗器材股份有限公司的首席财务官，自2008年5月起担任常州中金的首席财务官。曾于2006年1月至2008年4月担任日田常州电气有限公司首席财务官；1996年1月至2005年12月任常州伺服电机有限公司财务部经理。1992年8月至1995年12月，他在常州宝马集团担任财务官。Wang先生于1992年毕业于杭州电子技术学院，获得工业管理学士学位，2013年被江苏省人力资源和社会保障厅认证为高级经济学家。
- Ziqiang Wang,as the CFO of Changzhou Zhongjin since May 2008. Previously, from January 2006 to April 2008, he served as the CFO of Nikoda (Changzhou) Electric Co., Ltd; from January 1996 to December 2005, he served as the manager of the financial department at Changzhou Servo Motor Co., Ltd.; and from August 1992 to December 1995, he served as a financial officer at Changzhou BMW Group. Mr. Wang graduated from Hangzhou Institute of Electronic Technology with a Bachelor's degree in Industrial Management in 1992, and was certified as a Senior Economist by the Department of Human Resources and Social Security of Jiangsu Province in 2013.
- Oliver St. Clair Franklin
-
Oliver St. Clair Franklin，2021年1月至今，担任对冲基金Liminal Capital高级顾问。从2020年1月到2020年12月，Franklin先生在新冠疫情期间与多个非营利机构合作。Franklin先生于2019年4月至2019年12月担任FIS投资公司的高级顾问，并于2007年1月至2017年8月担任特拉华州雕像信托机构Academy Funds Trust的董事会主席。2006年11月至2018年12月，Franklin先生在Electronic Inc（Philadelphia）担任副董事长，Electronic Inc被法国公司Capgemini收购。Franklin先生曾于2001年1月至2006年9月担任International House的首席执行官。他是RISA Investments Advisers LLC（开普敦）的创始合伙人，1997年1月至2001年10月在那里工作。他曾担任富达投资（波士顿）高级副总裁，并在1991年9月至1996年6月期间担任机构投资领导团队的一员。他目前担任Dynamis Pharmaceuticals、Queen's Jubilee Education Trust、费城基金会的董事会成员，以及NatWest Banking Group（London）的顾问委员会成员。他拥有1966年林肯大学（PA）经济学学士学位，并在1967年至1970年期间担任牛津大学伍德罗·威尔逊研究员。他也是牛津大学巴利奥尔学院的荣誉院士。1995年，Franklin先生因其对英国金融服务业的服务而被女王陛下授予OBE荣誉。
Oliver St. Clair Franklin,has served as a senior adviser to Liminal Capital, a hedge fund, from January 2021 to the present. From January 2020 to December 2020, Mr. Franklin worked with various non-profit agencies amid the COVID-19 pandemic. Mr. Franklin was a senior advisor to FIS Investments from April 2019 to December 2019 and served as the Chairman of the Board of Directors of Academy Funds Trust, a Delaware statuary trust, from January 2007 to August 2017. From November 2006 to December 2018, Mr. Franklin served as a Vice Chairman at Electronic Inc (Philadelphia), which was acquired by Capgemini, a French company. Mr. Franklin was the CEO of International House from January 2001 to September 2006. He was a founding partner of RISA Investments Advisers LLC (Cape Town), and worked there from January 1997 to October 2001. He was a Senior Vice President of Fidelity Investments (Boston) and a part of the institutional investment leadership team from September 1991 to June 1996. He currently serves on the board of Dynamis Pharmaceuticals, the Queen's Jubilee Education Trust, The Philadelphia Foundation, as well as the Advisory Board of the NatWest Banking Group (London). He holds a Bachelor's degree in Economics from Lincoln University (PA) 1966 and was a Woodrow Wilson Fellow at Oxford University from 1967 to 1970. He is also a Honorary Fellow of Balliol College, Oxford. In 1995, Mr Franklin was bestowed the OBE Honor by Her Majesty the Queen for his services to the UK financial services industry. - Oliver St. Clair Franklin，2021年1月至今，担任对冲基金Liminal Capital高级顾问。从2020年1月到2020年12月，Franklin先生在新冠疫情期间与多个非营利机构合作。Franklin先生于2019年4月至2019年12月担任FIS投资公司的高级顾问，并于2007年1月至2017年8月担任特拉华州雕像信托机构Academy Funds Trust的董事会主席。2006年11月至2018年12月，Franklin先生在Electronic Inc（Philadelphia）担任副董事长，Electronic Inc被法国公司Capgemini收购。Franklin先生曾于2001年1月至2006年9月担任International House的首席执行官。他是RISA Investments Advisers LLC（开普敦）的创始合伙人，1997年1月至2001年10月在那里工作。他曾担任富达投资（波士顿）高级副总裁，并在1991年9月至1996年6月期间担任机构投资领导团队的一员。他目前担任Dynamis Pharmaceuticals、Queen's Jubilee Education Trust、费城基金会的董事会成员，以及NatWest Banking Group（London）的顾问委员会成员。他拥有1966年林肯大学（PA）经济学学士学位，并在1967年至1970年期间担任牛津大学伍德罗·威尔逊研究员。他也是牛津大学巴利奥尔学院的荣誉院士。1995年，Franklin先生因其对英国金融服务业的服务而被女王陛下授予OBE荣誉。
- Oliver St. Clair Franklin,has served as a senior adviser to Liminal Capital, a hedge fund, from January 2021 to the present. From January 2020 to December 2020, Mr. Franklin worked with various non-profit agencies amid the COVID-19 pandemic. Mr. Franklin was a senior advisor to FIS Investments from April 2019 to December 2019 and served as the Chairman of the Board of Directors of Academy Funds Trust, a Delaware statuary trust, from January 2007 to August 2017. From November 2006 to December 2018, Mr. Franklin served as a Vice Chairman at Electronic Inc (Philadelphia), which was acquired by Capgemini, a French company. Mr. Franklin was the CEO of International House from January 2001 to September 2006. He was a founding partner of RISA Investments Advisers LLC (Cape Town), and worked there from January 1997 to October 2001. He was a Senior Vice President of Fidelity Investments (Boston) and a part of the institutional investment leadership team from September 1991 to June 1996. He currently serves on the board of Dynamis Pharmaceuticals, the Queen's Jubilee Education Trust, The Philadelphia Foundation, as well as the Advisory Board of the NatWest Banking Group (London). He holds a Bachelor's degree in Economics from Lincoln University (PA) 1966 and was a Woodrow Wilson Fellow at Oxford University from 1967 to 1970. He is also a Honorary Fellow of Balliol College, Oxford. In 1995, Mr Franklin was bestowed the OBE Honor by Her Majesty the Queen for his services to the UK financial services industry.
- 童嘉元
-
童嘉元， 自2010年4月加入天银制药担任首席财务官、首席业务发展总监和董事。他是中国医疗保健投资银行在罗仕证券加利福尼亚州纽波特海滩的前主管；他一开始加入罗仕证券担任股票研究分析师，覆盖了一系列美国上市的中国制药，生物技术，医疗器械和药品零售业务。在此之前，他在纽约罗德曼公司担任生物技术分析师，覆盖专注于分子诊断和治疗阿尔茨海默病，多发性硬化症和癌症的生物技术。他曾经是海洋生物学实验室（由伍兹霍尔草基金会资助）的主要调查人；加州大学欧文分校文学硕士以及高级研究员。他被冷泉港实验室/石溪大学神经科学程序授予神经生物学和行为学博士学位。基于他对神经纤维瘤病- 1 （ NF1 ）中线粒体、老化和学习障碍的研究，他开发了一种创新的方法来显著延长动物的寿命。他出版了三篇创作性质的文章，目前拥有两项专利。 他持有北京大学健康科学中心的医学博士学位。
James Jiayuan Tong has served as independent director since November 2024. From 2020 until 2022, Dr. Tong has served as a Director and Venture Partner of Korean Investment Partner. From 2015 until 2020, Dr. Tong has served partner of Bison Capital (Beijing). Dr. Tong has served as a Venture Partner at Delta Capital, a venture capital and early growth investment firm, since September 2015. From December 2014 until September 2015, Dr. Tong worked as an advisor to Delta Capital. From 2010 to November 2014, he worked as Chief Financial Officer at Tianyin Pharmaceutical Co., Inc., a U.S. public company that manufactures and sells biopharmaceutical herbal medicines, branded generics and other pharmaceuticals in Asia. From 2008 to 2010, Dr. Tong worked as Vice President in the investment banking department at Roth Capital, an investment banking firm headquartered in Newport Beach, CA. In 2007, Dr. Tong was a biotech equity research analyst for Rodman & Renshaw. In 2006, Dr. Tong was principal investigator at the Grass Foundation Laboratory at the Marine Biological Laboratory, Woods Hole, MA. From 2002 to 2005, Dr. Tong was a Postdoctoral Research Fellow at Center for Molecular Medicine and Mitochondrial Genetics at the University of California, Irvine focing on Neurofibromatosis, cognitive disorders and longevity research. Dr. Tong graduated from Peking University Healthcare Center with a Medical Degree in 1996 and from Stony Brook University and Cold Spring Harbor Laboratory with a Doctor of Philosophy degree majored in Neurobiology and Behavior in 2002. Dr. Tong's research was published in vario high profile scientific jnals such as Nature, Nature Genetics and Cancer Cell. - 童嘉元， 自2010年4月加入天银制药担任首席财务官、首席业务发展总监和董事。他是中国医疗保健投资银行在罗仕证券加利福尼亚州纽波特海滩的前主管；他一开始加入罗仕证券担任股票研究分析师，覆盖了一系列美国上市的中国制药，生物技术，医疗器械和药品零售业务。在此之前，他在纽约罗德曼公司担任生物技术分析师，覆盖专注于分子诊断和治疗阿尔茨海默病，多发性硬化症和癌症的生物技术。他曾经是海洋生物学实验室（由伍兹霍尔草基金会资助）的主要调查人；加州大学欧文分校文学硕士以及高级研究员。他被冷泉港实验室/石溪大学神经科学程序授予神经生物学和行为学博士学位。基于他对神经纤维瘤病- 1 （ NF1 ）中线粒体、老化和学习障碍的研究，他开发了一种创新的方法来显著延长动物的寿命。他出版了三篇创作性质的文章，目前拥有两项专利。 他持有北京大学健康科学中心的医学博士学位。
- James Jiayuan Tong has served as independent director since November 2024. From 2020 until 2022, Dr. Tong has served as a Director and Venture Partner of Korean Investment Partner. From 2015 until 2020, Dr. Tong has served partner of Bison Capital (Beijing). Dr. Tong has served as a Venture Partner at Delta Capital, a venture capital and early growth investment firm, since September 2015. From December 2014 until September 2015, Dr. Tong worked as an advisor to Delta Capital. From 2010 to November 2014, he worked as Chief Financial Officer at Tianyin Pharmaceutical Co., Inc., a U.S. public company that manufactures and sells biopharmaceutical herbal medicines, branded generics and other pharmaceuticals in Asia. From 2008 to 2010, Dr. Tong worked as Vice President in the investment banking department at Roth Capital, an investment banking firm headquartered in Newport Beach, CA. In 2007, Dr. Tong was a biotech equity research analyst for Rodman & Renshaw. In 2006, Dr. Tong was principal investigator at the Grass Foundation Laboratory at the Marine Biological Laboratory, Woods Hole, MA. From 2002 to 2005, Dr. Tong was a Postdoctoral Research Fellow at Center for Molecular Medicine and Mitochondrial Genetics at the University of California, Irvine focing on Neurofibromatosis, cognitive disorders and longevity research. Dr. Tong graduated from Peking University Healthcare Center with a Medical Degree in 1996 and from Stony Brook University and Cold Spring Harbor Laboratory with a Doctor of Philosophy degree majored in Neurobiology and Behavior in 2002. Dr. Tong's research was published in vario high profile scientific jnals such as Nature, Nature Genetics and Cancer Cell.
高管简历
中英对照 | 中文 | 英文- Erqi Wang
Erqi Wang自2020年1月起担任中进医疗器材股份有限公司的首席执行官和董事长，自2006年10月成立公司以来，他一直担任常州中金的首席执行官和董事长。Wang先生也是中进医疗器材股份有限公司研发部门的核心领导。此前，2009年7月至2018年3月，Wang先生现任三桂康复设备上海有限公司董事总经理，他还担任江苏残疾人福利基金会名誉副会长，是中国轮椅协会的成员，Wang先生在中国获得了多项奖项，作为企业家和科学家，包括2013年度“常州市领先的企业家人才”和“中国的杰出企业家”。2008年“首届江苏省工业设计大赛银奖”。Wang先生拥有东北大学工程力学博士学位，作为第一位发明人拥有16项发明专利。
Erqi Wang,he has served as CEO and Chairman of Changzhou Zhongjin since he founded the company in October 2006. Mr. Wang is also a core leader of Jin Medical International Ltd. R&D department. Previously, from July 2009 to March 2018, Mr. Wang served as the managing director of Sangui Rehabilitation Equipment (Shanghai) Co., Ltd. Currently, he also serves as the Honorary Vice President of Jiangsu Welfare Foundation for the Disabled and is a member of the China Wheelchair Association Mr. Wang has received a number of awards in China for his achievements as an entrepreneur and as a scientist, including the "Leading Entrepreneurial Talent in Changzhou City" in 2013, and the "Silver Medal in the First Jiangsu Industrial Design Competition" in 2008. Mr. Wang holds a PhD in Engineering Mechanics from Tohoku University, and owns 16 invention patents as the first inventor.- Erqi Wang自2020年1月起担任中进医疗器材股份有限公司的首席执行官和董事长，自2006年10月成立公司以来，他一直担任常州中金的首席执行官和董事长。Wang先生也是中进医疗器材股份有限公司研发部门的核心领导。此前，2009年7月至2018年3月，Wang先生现任三桂康复设备上海有限公司董事总经理，他还担任江苏残疾人福利基金会名誉副会长，是中国轮椅协会的成员，Wang先生在中国获得了多项奖项，作为企业家和科学家，包括2013年度“常州市领先的企业家人才”和“中国的杰出企业家”。2008年“首届江苏省工业设计大赛银奖”。Wang先生拥有东北大学工程力学博士学位，作为第一位发明人拥有16项发明专利。
- Erqi Wang,he has served as CEO and Chairman of Changzhou Zhongjin since he founded the company in October 2006. Mr. Wang is also a core leader of Jin Medical International Ltd. R&D department. Previously, from July 2009 to March 2018, Mr. Wang served as the managing director of Sangui Rehabilitation Equipment (Shanghai) Co., Ltd. Currently, he also serves as the Honorary Vice President of Jiangsu Welfare Foundation for the Disabled and is a member of the China Wheelchair Association Mr. Wang has received a number of awards in China for his achievements as an entrepreneur and as a scientist, including the "Leading Entrepreneurial Talent in Changzhou City" in 2013, and the "Silver Medal in the First Jiangsu Industrial Design Competition" in 2008. Mr. Wang holds a PhD in Engineering Mechanics from Tohoku University, and owns 16 invention patents as the first inventor.
- Ziqiang Wang
Ziqiang Wang自2020年1月起担任中进医疗器材股份有限公司的首席财务官，自2008年5月起担任常州中金的首席财务官。曾于2006年1月至2008年4月担任日田常州电气有限公司首席财务官；1996年1月至2005年12月任常州伺服电机有限公司财务部经理。1992年8月至1995年12月，他在常州宝马集团担任财务官。Wang先生于1992年毕业于杭州电子技术学院，获得工业管理学士学位，2013年被江苏省人力资源和社会保障厅认证为高级经济学家。
Ziqiang Wang,as the CFO of Changzhou Zhongjin since May 2008. Previously, from January 2006 to April 2008, he served as the CFO of Nikoda (Changzhou) Electric Co., Ltd; from January 1996 to December 2005, he served as the manager of the financial department at Changzhou Servo Motor Co., Ltd.; and from August 1992 to December 1995, he served as a financial officer at Changzhou BMW Group. Mr. Wang graduated from Hangzhou Institute of Electronic Technology with a Bachelor's degree in Industrial Management in 1992, and was certified as a Senior Economist by the Department of Human Resources and Social Security of Jiangsu Province in 2013.- Ziqiang Wang自2020年1月起担任中进医疗器材股份有限公司的首席财务官，自2008年5月起担任常州中金的首席财务官。曾于2006年1月至2008年4月担任日田常州电气有限公司首席财务官；1996年1月至2005年12月任常州伺服电机有限公司财务部经理。1992年8月至1995年12月，他在常州宝马集团担任财务官。Wang先生于1992年毕业于杭州电子技术学院，获得工业管理学士学位，2013年被江苏省人力资源和社会保障厅认证为高级经济学家。
- Ziqiang Wang,as the CFO of Changzhou Zhongjin since May 2008. Previously, from January 2006 to April 2008, he served as the CFO of Nikoda (Changzhou) Electric Co., Ltd; from January 1996 to December 2005, he served as the manager of the financial department at Changzhou Servo Motor Co., Ltd.; and from August 1992 to December 1995, he served as a financial officer at Changzhou BMW Group. Mr. Wang graduated from Hangzhou Institute of Electronic Technology with a Bachelor's degree in Industrial Management in 1992, and was certified as a Senior Economist by the Department of Human Resources and Social Security of Jiangsu Province in 2013.